{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:58:28Z","timestamp":1791223108761,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.sapharm.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:38:50Z","timestamp":1782862730000},"page":"1119-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Do medication adherence trajectories predict clinical endpoints in a cohort with HIV and chronic comorbidities?"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-6279","authenticated-orcid":false,"given":"Michael J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeena R.","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.sapharm.2026.06.010_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2026.06.010_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54969-3","article-title":"Chronic disease onset among people living with HIV and AIDs in a large private insurance claims dataset","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib3","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/QAI.0000000000000556","article-title":"Geriatric syndromes in older HIV-Infected adults","volume":"69","author":"Greene","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.sapharm.2026.06.010_bib5","volume":"2","year":"2026"},{"key":"10.1016\/j.sapharm.2026.06.010_bib6","first-page":"97","article-title":"Chapter 6. The social aspects of drug use","volume":"vol. 45","author":"Haaijer -Ruskamp","year":"1993"},{"key":"10.1016\/j.sapharm.2026.06.010_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.sapharm.2026.06.010_bib8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ejhf.920","article-title":"'Drugs don't work in patients who don't take them' (C. Everett Koop, MD, US Surgeon General, 1985)","volume":"19","author":"Lindenfeld","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.sapharm.2026.06.010_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11606-017-4198-4","article-title":"Advancing the science and practice of medication adherence","volume":"33","author":"Stirratt","year":"2018","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2026.06.010_bib10","series-title":"Adherence to long-term Therapies: Evidence for Action","year":"2003"},{"key":"10.1016\/j.sapharm.2026.06.010_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAD.0000000000002384","article-title":"ART therapy adherence among treatment-naive HIV-infected patients","volume":"34","author":"Chakraborty","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.sapharm.2026.06.010_bib12","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1007\/s12325-021-01883-8","article-title":"Real-world adherence to ART therapy among HIV-1 patients across the United States","volume":"38","author":"McComsey","year":"2021","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.sapharm.2026.06.010_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0000000000003154","article-title":"Beyond antiretroviral treatment: patterns and factors associated with composite medication adherence before and during the COVID-19 pandemic in patients with HIV with multiple chronic conditions","volume":"92","author":"Miller","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.sapharm.2026.06.010_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/003335491112600403","article-title":"Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life","volume":"126","author":"Parekh","year":"2011","journal-title":"Publ Health Rep"},{"key":"10.1016\/j.sapharm.2026.06.010_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.010_bib17","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.010_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2026.06.010_bib19","series-title":"Pharmacy Quality Alliance","article-title":"Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Springfield (VA)","author":"Nau","year":"2012"},{"key":"10.1016\/j.sapharm.2026.06.010_bib20","series-title":"Measures and Resources","year":"2026"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/pop.2019.0052","article-title":"Benchmarking HIV quality measures across US payer types","volume":"23","author":"Priest","year":"2020","journal-title":"Popul Health Manag"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.010_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajhp\/zxab392","article-title":"Proportion of days covered as a measure of medication adherence","volume":"79","author":"Loucks","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2026.06.010_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence [published correction appears in Med Care. 2013 Nov;51(11):1029]","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"issue":"9","key":"10.1016\/j.sapharm.2026.06.010_bib25","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.010_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12981-023-00520-4","article-title":"Dual trajectories of antiretroviral therapy adherence and polypharmacy in women with HIV in the United States","volume":"20","author":"Elbur","year":"2023","journal-title":"AIDS Res Ther"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/QAI.0000000000003174","article-title":"Trajectories of antiretroviral therapy adherence and virologic failure in women with HIV in the United States","volume":"93","author":"Elbur","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.sapharm.2026.06.010_bib28","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.sapharm.2026.06.010_bib30","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2026.06.010_bib32","first-page":"S83","article-title":"6. Glycemic targets: standards of medical care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.010_bib33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"issue":"25","key":"10.1016\/j.sapharm.2026.06.010_bib34","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2026.06.010_bib35","year":"2024","journal-title":"Cholesterol"},{"key":"10.1016\/j.sapharm.2026.06.010_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0049124106292292","article-title":"Finite sample effects in group-based trajectory models","volume":"35","author":"Loughran","year":"2006","journal-title":"Socio Methods Res"},{"key":"10.1016\/j.sapharm.2026.06.010_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s10461-011-9955-5","article-title":"Optimizing the analysis of adherence interventions using logistic generalized estimating equations","volume":"16","author":"Huh","year":"2012","journal-title":"AIDS Behav"},{"key":"10.1016\/j.sapharm.2026.06.010_bib39","unstructured":"StataCorp LLC. Stata\/MP 18.0 for Windows, Revision 23 Sep 2025. College Station, TX."},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.010_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a Stata Plugin for estimating group-based trajectory models","volume":"42","author":"Jones","year":"2013","journal-title":"Socio Methods Res"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.010_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10865-012-9486-1","article-title":"Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes","volume":"37","author":"Batchelder","year":"2014","journal-title":"J Behav Med"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.010_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacl.2020.11.001","article-title":"One-year statin persistence and adherence in adults with HIV in the United States","volume":"15","author":"Crockett","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"8","key":"10.1016\/j.sapharm.2026.06.010_bib43","first-page":"809","article-title":"Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy","volume":"20","author":"Langness","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"10.1016\/j.sapharm.2026.06.010_bib44","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/hiv.13715","article-title":"Cardiovascular medication adherence testing in patients living with HIV: a single-centre observational study","volume":"25","author":"Nazareth","year":"2024","journal-title":"HIV Med"},{"issue":"11","key":"10.1016\/j.sapharm.2026.06.010_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/apc.2018.0079","article-title":"Impact of alternative encounter types on HIV viral suppression rates in an integrated health System","volume":"32","author":"Horberg","year":"2018","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"10.1016\/j.sapharm.2026.06.010_bib46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/apc.2020.0145","article-title":"Beyond the HIV care continuum and viral suppression: broadening the scope of quality metrics for total HIV patient care","volume":"34","author":"Horberg","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.010_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.18553\/jmcp.2026.32.4.507","article-title":"Transparent reporting of group-based trajectory modeling to study medication adherence: practical considerations and common pitfalls","volume":"32","author":"Rizk","year":"2026","journal-title":"J Manag Care Specialty Pharm"},{"key":"10.1016\/j.sapharm.2026.06.010_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ajhp\/zxae266","article-title":"Collaborative pharmacy research across integrated health systems: a purpose and promise for opportunities to study the complete medication-use process","volume":"82","author":"Olson","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.010_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.18553\/jmcp.2021.27.3.399","article-title":"Is it time to replace the star ratings adherence measures?","volume":"27","author":"Farley","year":"2021","journal-title":"J Manag Care Specialty Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.010_bib50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamainternmed.2024.0292","article-title":"Medication Adherence\u2014From measurer to measured","volume":"184","author":"Steiner","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sapharm.2026.06.010_bib51","series-title":"Health Affairs Forefront","article-title":"Why the star ratings medication adherence measures must Go","author":"DuBard","year":"2024"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:39:25Z","timestamp":1791221965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1551741126001609"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.06.010","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do medication adherence trajectories predict clinical endpoints in a cohort with HIV and chronic comorbidities?","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}